This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Mar;113(3):542.

doi: 10.1016/j.fertnstert.2019.12.015. Epub 2020 Feb 25.

MOXI trial-is it time to stop routinely recommending antioxidant therapy to infertile men?

Martin Kathrins¹

Affiliations

PMID: 32111472
DOI: 10.1016/j.fertnstert.2019.12.015

Free article

Editorial

MOXI trial-is it time to stop routinely recommending antioxidant therapy to infertile men?

Martin Kathrins. Fertil Steril. 2020 Mar.

Free article

. 2020 Mar;113(3):542.

doi: 10.1016/j.fertnstert.2019.12.015. Epub 2020 Feb 25.

Author

Martin Kathrins¹

Affiliation

¹ Division of Urology, Brigham and Women's Hospital, Boston, Massachusetts.

PMID: 32111472
DOI: 10.1016/j.fertnstert.2019.12.015

No abstract available

PubMed Disclaimer

Comment on

The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial.
Steiner AZ, Hansen KR, Barnhart KT, Cedars MI, Legro RS, Diamond MP, Krawetz SA, Usadi R, Baker VL, Coward RM, Huang H, Wild R, Masson P, Smith JF, Santoro N, Eisenberg E, Zhang H; Reproductive Medicine Network. Steiner AZ, et al. Fertil Steril. 2020 Mar;113(3):552-560.e3. doi: 10.1016/j.fertnstert.2019.11.008. Epub 2020 Feb 25. Fertil Steril. 2020. PMID: 32111479 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information